Béatrice Cazala is Executive Vice President, Commercial Operations, a Corporate Officer and member of the company’s Senior Management Team. She leads Global Commercialization and Global Policy and has operational responsibility for both Europe and China.

Under Béatrice’s leadership, Commercial Operations focuses on delivering value and accelerating the company’s BioPharma strategy through proactive innovation that strengthens our market access strategies, customer interface and strategic capabilities and processes. Given the complexity of commercializing small molecule and biologic products, Commercial Operations also collaborates in the development of global brands and strategies with other areas of the company, including R&D, Global Manufacturing and Supply, and Global Development and Medical Affairs, and our regions.

In her capacity as head of Global Policy, Béatrice leads the development and implementation of consistent and coordinated global external company policies across all regions.

“Our priority is to pursue innovative ways to make a difference in patients’ lives,” she says. “We live in a complex, rapidly evolving and competitive environment. Worldwide markets are more regulated, and governments and payors have increasing responsibility for setting pricing and reimbursement levels. We therefore have a shorter and shorter window of time to create value for customers and deliver advances in benefits to patients.”

Béatrice joined the company in 1982 as a product manager based in France. In her 30 years at the company, Béatrice has worked in functional capacities such as marketing and strategy, as well as leadership roles, including general manager, regional president and corporate management. She has also had oversight of several company geographies, including France, Italy, Northern Europe, Europe, the Middle East and Africa and Asia Pacific. Prior to joining Bristol-Myers Squibb, Béatrice spent five years at Laboratoires Cassenne (Aventis).

Béatrice is a member of the company’s Research and Development Executive Committee, the Research Operating Committee, and co-chair of the Product Development Operating Committee. She is also a member of both the board of trustees of the Bristol-Myers Squibb Foundation and the board of directors of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and is a member of the International Section Executive Committee of PhRMA.

Béatrice holds an MBA from the École Supérieure de Commerce et d’Administration des Entreprises (Rouen, France). In 2012, she was awarded la Légion d'honneur as a knight, the oldest and most prestigious decoration conferred by France.

November 2012